SEARCH
Cognoptix, Inc.
Acton, MA 01720 USA
Phone
Fax
Research Sector Biotech Specialty Pharma
Summary Description develops technology to detect Alzheimer's disease.
Management Paul Hartung, President and CEO; Gerald D. Cagle, PhD, Chief Operating Officer; Tom Trometer, Chief Financial Officer; Anne Cameron, PhD, Director, Marketing and Clinical Strategy; Ginny Kapner, General Counsel; Click here for Financial Data
Keywords: Diagnostics, Alzheimer's, Alzheimer, Alzheimers, biotech, eye, Ophthalmology, test
Updated: Oct. 22, 2015
Description
Cognoptix, a privately held medical technology company headquartered in Acton, Mass., is focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early de......view more
Products / Services
Fluorescent Ligand Scanning (FLS) is a technique in which a compound composed of beta amyloid-specific small molecules is dropped into a patient's eye, which is scanned by the SAPPHIRE instrument. ......view more
Technology / Differentiation
Cognoptix is developing technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye, to examine and measure deposits in specific areas of the lens as a means of earl...view more
Market / Customers
Alzheimer's Disease has long been recognized as a growing diagnostic and therapeutic challenge, with current medical detection methods limited to invasive, expensive, and unreliable tests that are una......view more